-
Mashup Score: 33RNA Biology Laboratory - 3 year(s) ago
We conduct cutting-edge research into the roles of RNAs and RNA protein complexes in cancer.
Source: Center for Cancer ResearchCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0
Adults with hematologic malignancies or solid tumors may be eligible to participate in a new clinical trial at the NIH Clinical Center. Elad Sharon, M.D., M.P.H., Senior Investigator at the National Cancer Institute, is leading a study to assess the effects of the Moderna COVID-19 vaccine (mRNA-1273) in adults undergoing treatment for various types of cancer.
Source: Center for Cancer ResearchCategories: General Medicine News, Latest HeadlinesTweet-
https://t.co/sky1ihCu2a
-
-
Mashup Score: 2
Comprehensive Oncology Network Evaluating Rare CNS Tumors NCI-CONNECT (Comprehensive Oncology Network Evaluating Rare CNS Tumors) aims to advance the understanding of rare adult central nervous system (CNS) cancers by establishing and fostering patient-advocacy-provider partnerships and networks to improve approaches to care and treatment.
Source: Center for Cancer ResearchCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
People diagnosed with rare brain and spine tumors, and researchers who study them, face unique challenges. NCI-CONNECT intends to address those challenges head on. Find out how. https://t.co/v7nEWgSUEN #NothingWillStopUs #CancerCare https://t.co/OemGtrcCl6
-
-
Mashup Score: 1Freddy E. Escorcia, M.D., Ph.D. - 3 year(s) ago
Advances in engineering of tumor-specific molecules to guide cytotoxic treatments, such as chemotherapy or radionuclides, have resulted in new classes of cancer drugs which have the potential to kill tumors while mitigating toxicities to normal tissues, moving us closer to truly tumor-targeted, personalized cancer treatment for our patients. Targeted radionuclide therapy
Source: Center for Cancer ResearchCategories: Hem/Oncs, Latest HeadlinesTweet-
🎉Congratulations Dr Escoria🎉@freddyeescorcia @theNCI Learn more about his research here: https://t.co/fOsRfkwSUx Learn more about the Early #PhysicianScientist Investigator program @NCIResearchCtr that helped launch his career #Lasker https://t.co/iKL8IFCUOa https://t.co/c251NOI854
-
-
Mashup Score: 26
Adults with hematologic malignancies or solid tumors may be eligible to participate in a new clinical trial at the NIH Clinical Center. Elad Sharon, M.D., M.P.H., Senior Investigator at the National Cancer Institute, is leading a study to assess the effects of the Moderna COVID-19 vaccine (mRNA-1273) in adults undergoing treatment for various types of cancer.
Source: Center for Cancer ResearchCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
A new clinical trial is studying the effects of the Moderna #COVID19 vaccine in adults undergoing treatment for various types of cancer: https://t.co/GFBHhw1nsl @NCIResearchCtr @EladSharonMD https://t.co/sydsAeE7An
-
-
Mashup Score: 6Personalized approach to prostate cancer diagnosis could mean less invasive biopsies - 3 year(s) ago
A more personalized approach to prostate cancer diagnosis could allow many men to undergo less invasive biopsy procedures without compromising accuracy, CCR scientists have found.
Source: Center for Cancer ResearchCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Personalized approach to prostate cancer diagnosis could mean less invasive biopsies: https://t.co/9hf2p7HRvR @NCIResearchCtr #prostatecancer https://t.co/FNakihYI5C
-
-
Mashup Score: 14
A clinical trial led by CCR physician-scientists found that long-term survival for children, adolescents and young adults with relapsed or refractory B-cell acute lymphoblastic leukemia (B-ALL) was significantly better for patients who received CD19-chimeric antigen receptor (CAR) T-cell therapy followed by a stem cell transplant, compared to CAR T-cell therapy alone. The patients were followed…
Source: Center for Cancer ResearchCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Stem cell transplant after CAR T-cell therapy is effective for young patients with leukemia: https://t.co/zEPWZUDGng @NCIResearchCtr #leukemia @NCI_CCR_PedOnc https://t.co/ew3UyYz5Db
-
-
Mashup Score: 9Clinical trial studies three immunotherapies given before surgery in newly diagnosed head and neck cancers not caused by HPV - 3 year(s) ago
Newly diagnosed head and neck cancer not caused by HPV infection often uses surgery as the first treatment. People with this type of cancer may be eligible to participate in this trial at the NIH Clinical Center.
Source: Center for Cancer ResearchCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
A new clinical trial is studying three #immunotherapy drugs given before surgery in newly diagnosed head and neck cancers not caused by HPV: https://t.co/qTQ5zoYVwa @NCIResearchCtr #hncsm https://t.co/uzJgWKDoA0
-
-
Mashup Score: 15
In an important advancement for precision oncology, CCR researchers have shown how their tumor analysis pipeline, called SELECT, can identify which therapies may be particularly beneficial for individual patients. When applied to data from over 30 different targeted and immunotherapy clinical trials, SELECT was successfully predictive of patient responses to these therapies in about 80 percent of…
Source: Center for Cancer ResearchCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
New tool predicts which treatments may work best in patients with cancer: https://t.co/F3nfAvXGz3 @NCIResearchCtr @NCIEytanRuppin #SynthEticLEthality https://t.co/EsqlOLalM0
-
-
Mashup Score: 2Clinical trial investigates vaccine to treat recurrent respiratory papillomatosis after surgery - 3 year(s) ago
Adults with recurrent respiratory papillomatosis (RRP) who have had at least two surgeries to reduce lesions in the last 12 months may be eligible to participate in a new clinical trial at the NIH Clinical Center.
Source: Center for Cancer ResearchCategories: Hem/Oncs, Latest HeadlinesTweet-
RT @theNCI: #ClinicalTrial investigates vaccine to treat recurrent respiratory papillomatosis after surgery: https://t.co/39xOKYOB51 @NCIRe…
-
RT @NCISandraWolin: Attention RNA Scientists: The NCI RNA Biology Laboratory https://t.co/aKGRJY9nVw is hiring tenure-track Investigators!…